HOPE for cardiovascular disease prevention with ACE-inhibitor ramipril. Heart Outcomes Prevention Evaluation
Kleinert, S.
Lancet 354(9181): 841
1999
ISSN/ISBN: 0140-6736 PMID: 10485736 Document Number: 507636
Document emailed within 1 workday
Related Documents
Chaturvedi, N. 2000: HOPE and extension of the indications for ACE inhibitors? Heart Outcomes Prevention Evaluation Lancet 355(9200): 246-247Hutcheon, S.D.; Gillespie, N.D.; McMurdo, M.E.; Struthers, A.D. 2000: HOPE and elderly patients attending geriatric day hospital. Heart Outcomes Prevention Evaluation Study Lancet 356(9228): 511-512
Tkacheva, O.N.; Sharashkina, N.V. 2010: Possibilities of ramipril in primary and secondary prevention of cardiovascular diseases Kardiologiia 50(8): 63-66
Jabbour, S.; Nishtar, S.; Prabhakaran, D.; Chockalingam, A.; Achutti, A.; Agrawal, A.; Luna, M.A.; Garofalo, F.; Wielgosz, A. 2003: Information and communication technology in cardiovascular disease prevention in developing countries: hype and hope. Report of the International Collaboration on Information Use in Cardiovascular Health Promotion in Developing Countries International Journal of Cardiology 92(2-3): 105-111
Stachenko, S. 1996: The Canadian Heart Health Initiative: a countrywide cardiovascular disease prevention strategy Journal of Human Hypertension 10 Suppl. 1: S5-S8
Muñoz, M.A.; Subirana, I.; Ramos, R.; Franzi, A.; Vila, J.; Marrugat, J. 2008: Efficacy of an intensive prevention programme of coronary heart disease: 5 year follow-up outcomes Medicina Clinica 130(14): 521-525
Bai, X-juan. 2011: Individual evaluation of biological aging and its relationship with advance prevention and treatment of cardiovascular disease Zhonghua Yi Xue Za Zhi 91(10): 649-650
Long Term Intervention With Pravastatin, I.Ischaemic Disease Study Group 1998: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels New England Journal of Medicine 339(19): 1349-1357
Sieradzki, J.; Huszno, B.; Mruk, K.; Magdoń, M.; Szybiński, Z. 1976: Questionnaire polling in evaluation of diet utilized in programme for prevention of coronary heart disease Przeglad Lekarski 33(6): 594-598
Kumanyika, S.K.; Obarzanek, E.; Stettler, N.; Bell, R.; Field, A.E.; Fortmann, S.P.; Franklin, B.A.; Gillman, M.W.; Lewis, C.E.; Poston, W.Carlos.; Stevens, J.; Hong, Y. 2008: Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (formerly the expert panel on population and prevention science) Circulation 118(4): 428-464
Kumanyika, S.K.; Obarzanek, E.; Stettler, N.; Bell, R.; Field, A.E.; Fortmann, S.P.; Franklin, B.A.; Gillman, M.W.; Lewis, C.E.; Poston, W.Carlos.; Stevens, J.; Hong, Y. 2008: Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (formerly the expert panel on population and prevention science) Circulation 118(4): 428-464
Enbergs, A.; Liese, A.; Heimbach, M.; Kerber, S.; Scheld, H.H.; Breithardt, G.; Kleine-Katthöfer, P.; Keil, U. 1997: Evaluation of secondary prevention of coronary heart disease. Results of the EUROSPIRE study in the Munster region Zeitschrift für Kardiologie 86(4): 284-291
Lowe, G.; Rumley, A.; Norrie, J.; Ford, I.; Shepherd, J.; Cobbe, S.; Macfarlane, P.; Packard, C. 2000: Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study Thrombosis and Haemostasis 84(4): 553-558
Stamler, J. 1973: Heart disease prevention in industry. Primary prevention in mass community efforts to control the major coronary risk factors: the challenges and possibilities--critical issues and outlook for the future Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 15(1): 54-59
Huo, Y.; Li, X.Y. 2018: Deepen our thoughts on the prevention of cardiovascular disease and actively contribute to the earlier appearance of the turning point noting the reduced prevalence of cardiovascular diseases Zhonghua Xin Xue Guan Bing Za Zhi 46(1): 3-6
1981: Evaluation strategy of the Swiss National Research Program on primary prevention of cardiovascular disease. Report of the Programme National Suisse de Recherche No. 1A. Groupe d'étude Revue d'Epidemiologie et de Sante Publique 29(3): 315-325
Kittel, F.; Kornitzer, M.; De Backer, G.; Dramaix, M. 1982: The Belgian Heart Disease Prevention Project: type A behavior pattern and the prevalence of coronary heart disease Activitas Nervosa Superior Suppl. 3(Pt 1): 78-83
Breckenkamp, J.; Laaser, U.; Meyer, S. 1995: The German Cardiovascular Prevention Study: social gradient for the net effects in prevention of hypercholesterolemia Zeitschrift für Kardiologie 84(9): 694-699
Ross, D; Morrison, T; Williams, R; Imbert, Y; Robinson, D; Burke, A.C. 2013: A Collaborative Approach to Clostridium difficile Infection Prevention: Utilizing Evidence-based Prevention Strategies to Improve Patient Outcomes American Journal of Infection Control 41(6): S123-S124
Ross, D; Morrison, T; Williams, R; Imbert, Y; Robinson, D; Burke, A.C. 2013: A Collaborative Approach to Clostridium difficile Infection Prevention: Utilizing Evidence-based Prevention Strategies to Improve Patient Outcomes American Journal of Infection Control 41(6): S123-S124